Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
PTC Therapeutics, Inc. (PTCT) had Non-Operating Income/Expense of $-36.09M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$178.88M |
|
$-64.85M |
|
$11.42M |
|
$167.46M |
|
$213.83M |
|
$-34.96M |
|
|
Non-Operating Income/Expense |
$-36.09M |
$-71.05M |
|
$-71.05M |
|
$-64.85M |
|
$-64.85M |
|
$-64.85M |
|
$-64.85M |
|
$-34.96M |
|
$-31.53M |
|
78.15M |
|
78.15M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$2.27B |
|
$57.19M |
|
$361.28M |
|
$2.63B |
|
$627.81M |
|
$2.13B |
|
$2.21B |
|
$2.84B |
|
$-206.55M |
|
$-432.69M |
|
$-206.55M |
|
79.38M |
|
| Cash Flow Statement Financials | |
$811.77M |
|
$-606.37M |
|
$13.37M |
|
$795.32M |
|
$1.03B |
|
$237.75M |
|
$36.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.62 |
|
-- |
|
-- |
|
1.11 |
|
-11.63 |
|
93.62% |
|
-19.54% |
|
-19.54% |
|
-- |
|
-39.72% |
|
-36.25% |
|
$808.80M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.34 |
|
0.91 |
|
98.68 |
|
31.40% |
|
14.99% |
|
-2.46% |
|
-3.36% |
|
$-2.60 |
|
$10.35 |
|
$10.39 |
|